Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
International Journal of Oncology
|
March 15, 2014
Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon
Shota Uekusa, Hiroyuki Kawashima, Kiminobu Sugito, et al.
Science (New York, N.Y.)
|
July 31, 2010
Planar cell polarity acts through septins to control collective cell movement and ciliogenesis
Su Kyoung Kim, Asako Shindo, Tae Joo Park, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 9, 2009
Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development
Martin R Müller, Yoshiteru Sasaki, Irena Stevanovic, et al.
Mabs
|
July 27, 2021
Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models
Sujatha Kumar, Srimoyee Ghosh, Geeta Sharma, et al.
Journal of Dermatological Science
|
July 27, 2010
Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation
Yui Shinojima, Tadashi Terui, Hiroyuki Hara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B
Diwakar Davar, Zeynep Eroglu, Mohammed Milhem, et al.
Pediatric Blood & Cancer
|
August 23, 2012
Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions
Kiminobu Sugito, Hiroyuki Kawashima, Shota Uekusa, et al.
Clinical Lung Cancer
|
June 21, 2022
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial
Victor Moreno, Desamparados Roda, Joanna Pikiel, et al.
BJC Reports
|
February 27, 2025
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours
J Randolph Hecht, Jean-Marie Michot, David Bajor, et al.
The Journal of Biological Chemistry
|
April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition
Srimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
International Journal of Oncology
|
March 15, 2014
Nr4a3, a possibile oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon
Shota Uekusa, Hiroyuki Kawashima, Kiminobu Sugito, et al.
Science (New York, N.Y.)
|
July 31, 2010
Planar cell polarity acts through septins to control collective cell movement and ciliogenesis
Su Kyoung Kim, Asako Shindo, Tae Joo Park, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 9, 2009
Requirement for balanced Ca/NFAT signaling in hematopoietic and embryonic development
Martin R Müller, Yoshiteru Sasaki, Irena Stevanovic, et al.
Mabs
|
July 27, 2021
Preclinical characterization of dostarlimab, a therapeutic anti-PD-1 antibody with potent activity to enhance immune function in in vitro cellular assays and in vivo animal models
Sujatha Kumar, Srimoyee Ghosh, Geeta Sharma, et al.
Journal of Dermatological Science
|
July 27, 2010
Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation
Yui Shinojima, Tadashi Terui, Hiroyuki Hara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B
Diwakar Davar, Zeynep Eroglu, Mohammed Milhem, et al.
Pediatric Blood & Cancer
|
August 23, 2012
Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions
Kiminobu Sugito, Hiroyuki Kawashima, Shota Uekusa, et al.
Clinical Lung Cancer
|
June 21, 2022
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial
Victor Moreno, Desamparados Roda, Joanna Pikiel, et al.
BJC Reports
|
February 27, 2025
CITRINO: phase 1 dose escalation study of anti-LAG-3 antibody encelimab alone or in combination with anti-PD-1 dostarlimab in patients with advanced/metastatic solid tumours
J Randolph Hecht, Jean-Marie Michot, David Bajor, et al.
The Journal of Biological Chemistry
|
April 9, 2016
Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition
Srimoyee Ghosh, Alexander Taylor, Melissa Chin, et al.
Page
of 4